These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 25798941)
1. The PKD inhibitor CID755673 enhances cardiac function in diabetic db/db mice. Venardos K; De Jong KA; Elkamie M; Connor T; McGee SL PLoS One; 2015; 10(3):e0120934. PubMed ID: 25798941 [TBL] [Abstract][Full Text] [Related]
2. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice. Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290 [TBL] [Abstract][Full Text] [Related]
3. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model. Liu X; Xu Q; Wang X; Zhao Z; Zhang L; Zhong L; Li L; Kang W; Zhang Y; Ge Z Pharmacol Res; 2015 Mar; 93():43-51. PubMed ID: 25617729 [TBL] [Abstract][Full Text] [Related]
4. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice. Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794 [TBL] [Abstract][Full Text] [Related]
5. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. Sharlow ER; Giridhar KV; LaValle CR; Chen J; Leimgruber S; Barrett R; Bravo-Altamirano K; Wipf P; Lazo JS; Wang QJ J Biol Chem; 2008 Nov; 283(48):33516-26. PubMed ID: 18829454 [TBL] [Abstract][Full Text] [Related]
6. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497 [TBL] [Abstract][Full Text] [Related]
7. Impaired cardiac functional reserve in type 2 diabetic db/db mice is associated with metabolic, but not structural, remodelling. Daniels A; van Bilsen M; Janssen BJ; Brouns AE; Cleutjens JP; Roemen TH; Schaart G; van der Velden J; van der Vusse GJ; van Nieuwenhoven FA Acta Physiol (Oxf); 2010 Sep; 200(1):11-22. PubMed ID: 20175764 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of protein kinase D by CID755673 promotes maintenance of the pluripotency of embryonic stem cells. Zhu Z; Zhang Y; Wang X; Wang X; Ye SD Development; 2020 Aug; 147(16):. PubMed ID: 32747433 [TBL] [Abstract][Full Text] [Related]
9. Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice. He Q; Pu J; Yuan A; Yao T; Ying X; Zhao Y; Xu L; Tong H; He B Cardiovasc Diabetol; 2014 Nov; 13():149. PubMed ID: 25416469 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Connelly KA; Kelly DJ; Zhang Y; Prior DL; Advani A; Cox AJ; Thai K; Krum H; Gilbert RE Circ Heart Fail; 2009 Mar; 2(2):129-37. PubMed ID: 19808328 [TBL] [Abstract][Full Text] [Related]
12. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice. Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911 [TBL] [Abstract][Full Text] [Related]
13. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension. Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354 [TBL] [Abstract][Full Text] [Related]
14. Protective effects of desacyl ghrelin on diabetic cardiomyopathy. Pei XM; Yung BY; Yip SP; Chan LW; Wong CS; Ying M; Siu PM Acta Diabetol; 2015 Apr; 52(2):293-306. PubMed ID: 25192951 [TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes. Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359 [TBL] [Abstract][Full Text] [Related]
17. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928 [TBL] [Abstract][Full Text] [Related]
18. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843 [TBL] [Abstract][Full Text] [Related]
19. Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice. Daltro PS; Alves PS; Castro MF; Azevedo CM; Vasconcelos JF; Allahdadi KJ; de Freitas LA; de Freitas Souza BS; Dos Santos RR; Soares MB; Macambira SG BMC Cardiovasc Disord; 2015 Dec; 15():162. PubMed ID: 26631050 [TBL] [Abstract][Full Text] [Related]
20. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels. Dludla PV; Essop MF; Gabuza KB; Muller CJF; Louw J; Johnson R Heart Vessels; 2017 Aug; 32(8):1025-1031. PubMed ID: 28393273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]